‘Doctor Strange In The Multiverse Of Madness’ Domestic Box Office Crosses $400M, 10th MCU Title To Do So

Film

More box office milestones here as the theatrical business bounces back and the pandemic eases: Disney/Marvel’s Doctor Strange in the Multiverse of Madness crossed $400M yesterday at the domestic box office during its 41st day of release.

The movie is still the second highest grossing film of 2022 to date behind Top Gun: Maverick, which beat it to $400M in 18 days, and now stands at $416M. In regards to the pandemic, Sony’s Spider-Man: No Way Home reigns as the highest grossing since mid-March 2020, both stateside and worldwide with $804.7M and $1.9 billion. After that in U.S./Canada, Top Gun: Maverick is second and Doctor Strange 2 is third.

Doctor Strange 2 is the tenth Disney MCU title to cross $400M in U.S./Canada after Avengers: Endgame ($858.3M), Spider-Man: No Way Home, Black Panther ($700.4M), Avengers: Infinity War ($678.8M), The Avengers ($623.3M), Avengers: Age of Ultron ($459M), Captain Marvel ($426.8M), Iron Man 3 ($409M) and Captain America: Civil War ($408M).

Doctor Strange 2 became director Sam Raimi’s highest grossing movie ever on a global basis some time ago, surpassing Spider-Man 3 ($895M), and with a current worldwide take of $935.3M ($535M overseas). However, on a domestic basis, Doctor Strange 2 is the director’s second highest grossing after 2002’s Spider-Man which stands at $407M.

We hear that a final endgame worldwide for Doctor Strange 2 is around $950M. Without a China and Russia release, a billion dollar endgame for this MCU title doesn’t appear possible.

More Marvel is on the way with Thor: Love & Thunder on July 8 and Black Panther: Wakanda Forever on Nov. 11.

Products You May Like

Articles You May Like

Should ‘High Potential’ Revisit the Missing Roman Mystery?
HBO Releases Trailer for New Yacht Rock Documentary: Watch
Zendaya and Anne Hathaway Join Christopher Nolan’s New Movie
Watch ‘Weird Al’ Yankovic and Will Forte cover Chappell Roan’s ‘Hot To Go!’ at benefit concert
GM’s Wall Street vindication is here as it outperforms peers in 2024